JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v10i5.15244ArticleSystematic Review of Risk Factors for Cognitive Dysfunction and Nursing Intervention Models in Elderly Patients with Type 2 Diabetes Mellitushttps://artdesignp.com/journal/JCNR/10/5/10.26689/jcnr.v10i5.15244PengDonglin,ZhangJinyu,ZhaoWei20261052026-05-31Background: Type 2 diabetes mellitus (T2DM) is a common chronic metabolic disorder among the elderly, with a significantly higher incidence of cognitive dysfunction compared to the general population. Objective: To systematically evaluate the risk factors for cognitive dysfunction and the efficacy of nursing interventions in elderly T2DM patients, providing a basis for early clinical identification and comprehensive care. Methods: Literature was retrieved from databases including China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, and PubMed, encompassing Chinese and English publications on risk factors and nursing interventions for cognitive dysfunction in elderly T2DM patients from 2024 to 2026. Two researchers independently conducted literature screening and data extraction. Results: A total of 17 studies were included. Independent risk factors for cognitive dysfunction in elderly T2DM patients included elevated glycated hemoglobin (HbA1c), prolonged diabetes duration, advanced age, high triglycerides, elevated low-density lipoprotein cholesterol (LDL-C), hypertension, and increased serum inflammatory markers. Regarding nursing intervention models, specialized community-based interventions and hyperbaric oxygen therapy combined with Baduanjin exercise effectively improved cognitive function. Conclusion: Clinical practice should emphasize glycemic control in elderly T2DM patients, strengthen early screening for high-risk populations, and adopt diversified nursing intervention approaches to delay cognitive decline.

Li J, Zhang Y, Che Y, et al., 2026, Study on Metabolomic Differences in Cognitive Dysfunction Among Elderly Patients with Type 2 Diabetes Mellitus. China Journal of Diabetes, 34(04): 264–270.

Liu C, Yang Y, Wang J, et al., 2026, Correlation Between Enlarged Perivascular Space Distribution and Cognitive Dysfunction in Elderly Patients with Type 2 Diabetes Mellitus. Chinese Journal of Geriatric Cardiovascular and Cerebrovascular Diseases, 28(04): 496–500.

Yan J, Zhang X, 2026, Predictive Value of Serum Interleukin-6 and C-Reactive Protein for Cognitive Dysfunction in Elderly Patients with Type 2 Diabetes Mellitus. China Contemporary Medicine, 33(06): 39–42.

Wang Y, Zhang X, Bu L, 2026, Risk Factors and Predictive Model Construction for Mild Cognitive Impairment in Elderly Patients with Type 2 Diabetes Mellitus. Journal of Practical Clinical Medicine, 30(01): 92–98.

He P, Liu Y, Li Y, et al., 2025, Application Study on the Assessment of Mild Cognitive Impairment Risk in Patients with Type 2 Diabetes Mellitus Based on QSM Combined with DTI. Ningxia Medical Journal, 47(12): 1053–1057.

Li D, Bao X, Tian L, et al., 2025, Factors Influencing Mild Cognitive Impairment in Elderly Patients with Type 2 Diabetes Mellitus. Diabetes New World, 28(21): 8–12.

Shui M, Zhao D, Wei J, 2025, Study on the Correlation Between TIR and Cognitive Dysfunction in Elderly Patients with Type 2 Diabetes Mellitus. Chinese Journal of Health Care Medicine, 27(05): 824–827.

Zhang X, Xu P, Han Z, 2025, The Impact of Diabetes Self-Management Behavior on the Risk of Mild Cognitive Impairment in Elderly Patients with Type 2 Diabetes Mellitus. International Journal of Nursing, 44(20): 3689–3694.

Wang X, 2025, Influencing Factors of Cognitive Dysfunction in Elderly Patients with Type 2 Diabetes Mellitus. Diabetes New World, 28(19): 30–32 + 48.

Zhang F, Xu N, Fan K, 2025, Influencing Factors of Amnestic Mild Cognitive Impairment in Elderly Patients with Type 2 Diabetes Mellitus. Diabetes New World, 28(15): 48–51.

Zhang W, Jiang L, Wu J, 2025, Research Progress on the Relationship Between Sarcopenia and Cognitive Dysfunction in Elderly Patients with Type 2 Diabetes Mellitus. Chinese Journal of Diabetes, 17(04): 510–514.

Zhu R, Liu C, He Y, et al., 2025, Study on the Predictive Value of Visceral Fat Area and Low-Density Lipoprotein Cholesterol in Cognitive Dysfunction Among Elderly Patients with Type 2 Diabetes Mellitus. China Medical Guide, 23(09): 1–5.

Cao M, Gao X, Liu B, 2025, Predictive Value of Urinary AD7c-NTP Combined with HbA1c for Cognitive Dysfunction in Elderly Patients with Type 2 Diabetes Mellitus. Corps Medical Journal, 23(01): 35–40.

Fan F, Liu C, Xing H, et al., 2025, Serum Levels of Nesfatin-1 and Klotho in Elderly Patients with Type 2 Diabetes Mellitus and Their Predictive Value for Secondary Mild Cognitive Impairment. International Journal of Laboratory Medicine, 46(05): 553–557.

Ma J, Yu Y, Han X, et al., 2025, Correlation Analysis of Serum Decorin and Biglycan with Cognitive Dysfunction in Elderly Patients with Type 2 Diabetes Mellitus. Health Care Medical Research and Practice, 22(01): 41–47.

Zhang L, Wang Y, Kan L, et al., 2024, Study on the Correlation Between Urinary Albumin/Creatinine Levels and Amnestic Mild Cognitive Impairment in Elderly Patients with Type 2 Diabetes Mellitus. China Journal of Neuropsychiatric Diseases, 50(12): 719–725.

Wang L, Jia X, Guo Y, et al., 2024, Correlation Between 1,5-Dehydroraffinose Levels and Mild Cognitive Impairment in Elderly Patients with Type 2 Diabetes Mellitus. Chinese Journal of Behavioral Medicine and Brain Science, 33(07): 618–623.

Ma J, Zhang M, Zhang S, et al., 2024, Study on the Influencing Factors of Mild Cognitive Impairment in Elderly Patients with Type 2 Diabetes Mellitus Under Community Management. China General Practice, 27(16): 1984–1989.

Shen H, Meng Z, Hou Y, et al., 2024, Efficacy of Hyperbaric Oxygen Therapy Combined with Baduanjin Exercise in Elderly Patients with Type 2 Diabetes Mellitus and Mild Cognitive Impairment. Jiangsu Medical Journal, 50(06): 614–617.

Ma J, Zhang M, Zhang S, 2024, Community Intervention Study on Elderly Patients with Type 2 Diabetes Mellitus and Mild Cognitive Impairment. Jilin Medical Journal, 45(07): 1587–1591.